Department of Molecular, University of California, Los Angeles
Affiliated withUniversity of California, Los Angeles
Research Area
Andrew Goldstein, Ph.D., is an Assistant Professor-In-Residence in the departments of Urology and Molecular, Cell, & Developmental Biology, and a member of the Broad Stem Cell Research Center and Jonsson Comprehensive Cancer Center at UCLA. Dr. Goldstein attended Dartmouth College in Hanover, New Hampshire where he majored in Biochemistry and Molecular Biology and was a two-time NCAA Division 1 All-American lacrosse player. Dr. Goldstein moved to UCLA where he completed his Ph.D. in the laboratory of Dr. Owen Witte, isolating epithelial progenitor cells from mouse and human prostate tissue and demonstrating the capacity of progenitor cells to respond to oncogenic transformation. This work included the first demonstration of a cell of origin for human prostate cancer reported in Science Magazine. In 2011, Dr. Goldstein became the Inaugural fellow of the Broad Stem Cell Research Center and received a Prostate Cancer Foundation Young Investigator Award and a Department of Defense Prostate Cancer Research Program Idea Development Award to elucidate the cellular and molecular mechanisms promoting epithelial cancer initiation, progression and resistance to treatment. Dr. Goldstein was awarded the 2018 Giants of Science Hope Award from the American Cancer Society and a 2019 Young Investigator Award from the Society for Basic Urologic Research.
Article Total : 1 | Year |
|---|---|
![]() Publication title Cited by 10 | 2019 |
Article | Year |
|---|---|
The many ways to make a luminal cell and a prostate cancer cell. Endocrine-related cancer| PubMed ID: 26307022 | 2015 |
| 2016 | |
HoxB13 mediates AR-V7 activity in prostate cancer. Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 29891672 | 2018 |